AJR Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Di Chiro, G
Right arrow Articles by Kufta, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Di Chiro, G
Right arrow Articles by Kufta, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
American Journal of Roentgenology, Vol 150, Issue 1, 189-197
Copyright © 1988 by American Roentgen Ray Society


Articles

Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies

G Di Chiro, E Oldfield, DC Wright, D De Michele, DA Katz, NJ Patronas, JL Doppman, SM Larson, M Ito, and CV Kufta

Neuroimaging Section, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, MD 20892.

Cerebral necrosis after radiotherapy for brain tumors is being recognized as a problem more common than previously estimated. Distinction between this iatrogenic complication and tumor recurrence cannot be made by either CT or MR imaging. By using positron emission tomography (PET) with 18F-deoxyglucose (FDG) we were able to reach a diagnosis of radiation necrosis, later verified, in 10 of 95 patients referred for the purpose of differentiating tumor recurrence from necrosis. The critical PET-FDG feature was focal hypometabolism in the area of necrosis, which contrasted with the hypermetabolism associated with the residual/recurrent tumor. In addition, four cases of cerebral necrosis after supraophthalmic, intraarterial chemotherapy (BCNU) were studied with the PET-FDG method. The area of chemotherapy damage was also characterized by marked hypometabolism. Histology revealed both similarities and differences between radio- and chemonecrosis.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JNMHome page
Y. Terakawa, N. Tsuyuguchi, Y. Iwai, K. Yamanaka, S. Higashiyama, T. Takami, and K. Ohata
Diagnostic Accuracy of 11C-Methionine PET for Differentiation of Recurrent Brain Tumors from Radiation Necrosis After Radiotherapy
J. Nucl. Med., May 1, 2008; 49(5): 694 - 699.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
A. A. Brandes, A. Tosoni, F. Spagnolli, G. Frezza, M. Leonardi, F. Calbucci, and E. Franceschi
Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology
Neuro-oncol, January 1, 2008; 10(3): 361 - 367.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
W. Chen
Clinical Applications of PET in Brain Tumors
J. Nucl. Med., September 1, 2007; 48(9): 1468 - 1481.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. Y. Kim, S.-w. Lee, S. Y. Nam, K. C. Im, J.-S. Kim, S. J. Oh, S. D. Ahn, S. S. Shin, E. K. Choi, and J. H. Kim
The Feasibility of 18F-FDG PET Scans 1 Month After Completing Radiotherapy of Squamous Cell Carcinoma of the Head and Neck
J. Nucl. Med., March 1, 2007; 48(3): 373 - 378.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S. Ceyssens, K. Van Laere, T. de Groot, J. Goffin, G. Bormans, and L. Mortelmans
[11C]Methionine PET, Histopathology, and Survival in Primary Brain Tumors and Recurrence
AJNR Am. J. Neuroradiol., August 1, 2006; 27(7): 1432 - 1437.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
W. Chen, D. H.S. Silverman, S. Delaloye, J. Czernin, N. Kamdar, W. Pope, N. Satyamurthy, C. Schiepers, and T. Cloughesy
18F-FDOPA PET Imaging of Brain Tumors: Comparison Study with 18F-FDG PET and Evaluation of Diagnostic Accuracy
J. Nucl. Med., June 1, 2006; 47(6): 904 - 911.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
M. B. Fukui, T. M. Blodgett, C. H. Snyderman, J. J. Johnson, E. N. Myers, D. W. Townsend, and C. C. Meltzer
Combined PET-CT in the Head and Neck: Part 2. Diagnostic Uses and Pitfalls of Oncologic Imaging
RadioGraphics, July 1, 2005; 25(4): 913 - 930.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
W. Chen, T. Cloughesy, N. Kamdar, N. Satyamurthy, M. Bergsneider, L. Liau, P. Mischel, J. Czernin, M. E. Phelps, and D. H.S. Silverman
Imaging Proliferation in Brain Tumors with 18F-FLT PET: Comparison with 18F-FDG
J. Nucl. Med., June 1, 2005; 46(6): 945 - 952.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
L. Borgwardt, L. Hojgaard, H. Carstensen, H. Laursen, M. Nowak, C. Thomsen, and K. Schmiegelow
Increased Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose (FDG) Uptake in Childhood CNS Tumors Is Correlated With Malignancy Grade: A Study With FDG Positron Emission Tomography/Magnetic Resonance Imaging Coregistration and Image Fusion
J. Clin. Oncol., May 1, 2005; 23(13): 3030 - 3037.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
J B Bingham
Where can FDG-PET contribute most to anatomical imaging problems?
Br. J. Radiol., November 1, 2002; 75(90009): S39 - 52.
[Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
H.-P. Schlemmer, P. Bachert, K. K. Herfarth, I. Zuna, J. Debus, and G. van Kaick
Proton MR Spectroscopic Evaluation of Suspicious Brain Lesions After Stereotactic Radiotherapy
AJNR Am. J. Neuroradiol., August 1, 2001; 22(7): 1316 - 1324.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. D. Langleben and G. M. Segall
PET in Differentiation of Recurrent Brain Tumor from Radiation Injury
J. Nucl. Med., November 1, 2000; 41(11): 1861 - 1867.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
A. J. Kumar, N. E. Leeds, G. N. Fuller, P. Van Tassel, M. H. Maor, R. E. Sawaya, and V. A. Levin
Malignant Gliomas: MR Imaging Spectrum of Radiation Therapy- and Chemotherapy-induced Necrosis of the Brain after Treatment
Radiology, November 1, 2000; 217(2): 377 - 384.
[Abstract] [Full Text]


Home page
J Child NeurolHome page
J. M. Wilmshurst, S. F. Barrington, D. Pritchard, T. Cox, P. Bullock, M. Maisey, and R. O. Robinson
Positron Emission Tomography in Imaging Spinal Cord Tumors
J Child Neurol, July 1, 2000; 15(7): 465 - 472.
[Abstract] [PDF]


Home page
Clin. Cancer Res.Home page
H. J. Aronen, F. S. Pardo, D. N. Kennedy, J. W. Belliveau, S. D. Packard, D. W. Hsu, F. H. Hochberg, A. J. Fischman, and B. R. Rosen
High Microvascular Blood Volume Is Associated with High Glucose Uptake and Tumor Angiogenesis in Human Gliomas
Clin. Cancer Res., June 1, 2000; 6(6): 2189 - 2200.
[Abstract] [Full Text]


Home page
Am. J. Neuroradiol.Home page
T. Sugahara, Y. Korogi, S. Tomiguchi, Y. Shigematsu, I. Ikushima, T. Kira, L. Liang, Y. Ushio, and M. Takahashi
Posttherapeutic Intraaxial Brain Tumor: The Value of Perfusion-sensitive Contrast-enhanced MR Imaging for Differentiating Tumor Recurrence from Nonneoplastic Contrast-enhancing Tissue
AJNR Am. J. Neuroradiol., May 1, 2000; 21(5): 901 - 909.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
L. Aloj, C. Caraco, E. Jagoda, W. C. Eckelman, and R. D. Neumann
Glut-1 and Hexokinase Expression: Relationship with 2-Fluoro-2-deoxy-D-glucose Uptake in A431 and T47D Cells in Culture
Cancer Res., September 1, 1999; 59(18): 4709 - 4714.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. U Berlangieri, A. M Scott, S. R Knight, G. J Fitt, O. F Hennessy, H. J Tochon-Danguy, C Peter Clarke, and W John McKay
F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer
Eur. J. Cardiothorac. Surg., September 1, 1999; 16(suppl_1): S25 - S30.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
R O Robinson, C D Ferrie, M Capra, and M N Maisey
Positron emission tomography and the central nervous system
Arch. Dis. Child., September 1, 1999; 81(3): 263 - 270.
[Full Text]


Home page
Arch SurgHome page
D. Delbeke, W. H. Martin, M. P. Sandler, W. C. Chapman, J. K. Wright Jr, and C. W. Pinson
Evaluation of Benign vs Malignant Hepatic Lesions With Positron Emission Tomography
Arch Surg, May 1, 1998; 133(5): 510 - 516.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S. Cha, E. A. Knopp, G. Johnson, S. G. Wetzel, A. W. Litt, and D. Zagzag
Intracranial Mass Lesions: Dynamic Contrast-enhanced Susceptibility-weighted Echo-planar Perfusion MR Imaging
Radiology, April 1, 2002; 223(1): 11 - 29.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Roentgen Ray Society.